Information  X 
Enter a valid email address

Target Healthcare (THRL)

  Print      Mail a friend

Monday 15 October, 2018

Target Healthcare

Publication of Supplementary Prospectus

RNS Number : 1127E
Target Healthcare REIT Limited
15 October 2018


15 OCTOBER 2018


Target Healthcare REIT Limited (the "Company") has today published a supplementary prospectus approved by the UK Listing Authority. The publication of the supplementary prospectus is a regulatory requirement under the Prospectus Rules following the publication of the Company's annual accounts for the year ended 30 June 2018.

The supplementary prospectus is supplemental to, and should be read in conjunction with, the prospectus published by the Company on 1 February 2018 in relation to the issue of ordinary shares pursuant to an initial placing, offer for subscription, open offer and placing programme.

A copy of the supplementary prospectus will shortly be available for inspection at the National Storage Mechanism which is located at

The supplementary prospectus is also available in electronic form on the Company's website at and available for collection during normal business hours on any day (Saturday, Sunday and public holidays excepted) until 31 January 2019 at the offices of Dickson Minto W.S., Broadgate Tower, 20 Primrose Street, London EC2A 2EW.


Target Fund Managers Limited



Kenneth MacKenzie


01786 845 912




Stifel Nicolaus Europe Limited



Mark Young

[email protected]

+44 20 7710 7600

Neil Winward

[email protected]

+44 20 7710 7600

Tom Yeadon

[email protected]

+44 20 7710 7600




Maitland Administration Services (Scotland) Limited



Martin Cassels

[email protected]

0131 550 3760




FTI Consulting



Dido Laurimore

[email protected]

0203 727 1000

Claire Turvey



Richard Gotla




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t